Per Tornvall Selected Research

Per Tornvall Research Topics

Disease

24	Myocardial Infarction 09/2023 - 04/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 04/2003
17	Inflammation (Inflammations) 09/2023 - 05/2003
11	ST Elevation Myocardial Infarction 11/2021 - 09/2005
9	MINOCA 12/2023 - 01/2018
8	Takotsubo Cardiomyopathy 11/2021 - 01/2013
8	Cardiovascular Diseases (Cardiovascular Disease) 03/2018 - 08/2003
6	Atrial Fibrillation 11/2023 - 04/2009
6	Atherosclerosis 01/2023 - 04/2003
6	Coronary Disease (Coronary Heart Disease) 01/2018 - 11/2004
5	Infarction (Infarctions) 11/2021 - 03/2013
4	Acute Coronary Syndrome 03/2024 - 02/2007
4	Infections 09/2023 - 05/2005
4	Thrombosis (Thrombus) 01/2018 - 07/2012
4	Stable Angina 01/2014 - 05/2005
3	Heart Failure 05/2020 - 06/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 12/2007
3	Neoplasms (Cancer) 09/2013 - 11/2004
3	Unstable Angina 12/2007 - 11/2005
3	Coronary Stenosis (Coronary Artery Stenosis) 12/2007 - 06/2002
2	Heart Arrest (Cardiac Arrest) 11/2023 - 02/2010
2	Hemorrhage 01/2018 - 11/2014
2	Non-ST Elevated Myocardial Infarction 11/2017 - 06/2016
2	Reperfusion Injury 10/2013 - 09/2005
2	Ischemia 10/2013 - 12/2007
2	Malaria 10/2011 - 01/2010
2	Hypertension (High Blood Pressure) 03/2011 - 02/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2004 - 12/2003
1	Thrombophilia 01/2022
1	Pheochromocytoma 11/2021
1	Severe Acute Respiratory Syndrome 11/2021
1	Iron Deficiencies 05/2020
1	Cytokine Release Syndrome 01/2020
1	COVID-19 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Pathologic Constriction (Stenosis) 01/2018
1	Heart Diseases (Heart Disease) 01/2018

Drug/Important Bio-Agent (IBA)

14	C-Reactive ProteinIBA 01/2023 - 05/2003
12	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2003
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2003
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 09/2012
4	CytokinesIBA 01/2020 - 10/2011
4	Troponin T (Troponin T1)IBA 01/2018 - 11/2005
4	trans-sodium crocetinate (crocetin)IBA 04/2016 - 01/2014
3	Immunoglobulin G (IgG)IBA 01/2022 - 03/2015
3	Atorvastatin (Lipitor)FDA Link 09/2013 - 04/2009
3	Plasminogen Activator Inhibitor 1IBA 09/2012 - 11/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2005
2	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 11/2023 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2019
2	CatecholaminesIBA 11/2021 - 01/2018
2	AntibodiesIBA 11/2021 - 02/2011
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 11/2016
2	LipidsIBA 01/2020 - 01/2005
2	TicagrelorIBA 01/2019 - 11/2017
2	Dobutamine FDA LinkGeneric 07/2015 - 12/2014
2	AutoantibodiesIBA 03/2015 - 04/2003
2	InterleukinsIBA 10/2012 - 10/2006
2	NF-kappa B (NF-kB)IBA 08/2010 - 03/2010
2	Fibrinogen (Factor I)FDA Link 07/2008 - 03/2005
2	Factor VII (Proconvertin)IBA 07/2007 - 08/2005
1	Protein C InhibitorIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Protein CIBA 01/2022
1	Antiphospholipid AntibodiesIBA 01/2022
1	Cardiolipins (Cardiolipin)IBA 01/2022
1	MetanephrineIBA 11/2021
1	NormetanephrineIBA 11/2021
1	ArginaseIBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	IronIBA 05/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	EicosanoidsIBA 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019
1	Agouti-Related ProteinIBA 01/2019
1	CreatinineIBA 01/2019
1	methylnaltrexone FDA Link 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	P-SelectinIBA 01/2019
1	ChemokinesIBA 01/2019
1	LigandsIBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	ReninIBA 01/2019
1	LDL CholesterolIBA 01/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2018

Therapy/Procedure

10	Percutaneous Coronary Intervention 11/2017 - 06/2002
8	Therapeutics 01/2021 - 01/2005
5	Stents 01/2018 - 05/2005
3	Electric Countershock (Cardioversion) 01/2021 - 04/2009
2	Secondary Prevention 01/2021 - 01/2018
2	Catheters 01/2014 - 05/2011
2	Radiotherapy 09/2013 - 03/2010